Allurion Technologies, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Allurion Technologies, Inc. (ALUR) reported Net Income (Loss) Available to Common Stockholders, Basic of -$11.88 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-17.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2025-11-17
- Allurion Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$11.88M, a 236.03% decline year-over-year.
- Allurion Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-03-31 was -$1.50M, a 175.20% decline year-over-year.
- Allurion Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-12-31 was -$9.61M.
- Allurion Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-09-30 was $8.74M.
- Allurion Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$7.20M.
- Allurion Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$84.51M.
- Allurion Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was -$40.65M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -$11.88M 10-Q · filed 2025-11-17 | -$22.72M 10-Q · filed 2025-11-17 | ||||||
| 2025-03-31 | -$1.50M 10-Q/A · filed 2025-08-19 | $7.38M 10-Q · filed 2025-05-15 | -$11.11M derived: sum of 2 quarters · filed 2025-08-19 | -$2.37M derived: sum of 3 quarters · filed 2025-11-17 | -$10.70M derived: sum of 4 quarters · filed 2025-11-17 | |||
| 2024-12-31 | -$9.61M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-19 | -$872.00K derived: sum of 2 quarters · filed 2025-11-17 | -$9.19M derived: sum of 3 quarters · filed 2025-11-17 | -$7.20M 10-K/A · filed 2025-08-19 | -$26.15M 10-K · filed 2025-03-27 | |||
| 2024-09-30 | $8.74M 10-Q · filed 2025-11-17 | -$9.00M 10-Q · filed 2024-11-13 | $414.00K derived: sum of 2 quarters · filed 2025-11-17 | $2.41M 10-Q · filed 2025-11-17 | -$5.58M 10-Q · filed 2024-11-13 | -$18.98M derived: sum of 4 quarters · filed 2025-11-17 | ||
| 2024-06-30 | -$8.32M 10-Q/A · filed 2025-08-28 | -$2.16M 10-Q · filed 2024-08-14 | -$6.33M 10-Q/A · filed 2025-08-28 | $3.42M 10-Q · filed 2024-08-14 | -$27.72M derived: sum of 3 quarters · filed 2025-08-28 | -$49.60M derived: sum of 4 quarters · filed 2025-08-28 | ||
| 2024-03-31 | $2.00M 10-Q/A · filed 2025-08-28 | $5.59M 10-Q · filed 2024-05-14 | -$19.39M derived: sum of 2 quarters · filed 2025-08-28 | -$41.28M derived: sum of 3 quarters · filed 2025-08-28 | -$64.00M derived: sum of 4 quarters · filed 2025-08-28 | |||
| 2023-12-31 | -$21.39M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | -$43.27M derived: sum of 2 quarters · filed 2025-08-28 | -$66.00M derived: sum of 3 quarters · filed 2025-08-28 | -$84.51M 10-K/A · filed 2025-08-28 | -$82.30M 10-K · filed 2024-03-26 | |||
| 2023-09-30 | -$21.89M 10-Q/A · filed 2025-08-28 | -$44.61M derived: sum of 2 quarters · filed 2025-08-28 | -$63.12M 10-Q/A · filed 2025-08-28 | -$76.20M derived: sum of 4 quarters · filed 2025-08-28 | ||||
| 2023-06-30 | -$22.72M 10-Q/A · filed 2025-08-28 | -$41.24M 10-Q/A · filed 2025-08-28 | -$54.32M derived: sum of 3 quarters · filed 2025-08-28 | -$68.62M derived: sum of 4 quarters · filed 2025-08-28 | ||||
| 2023-03-31 | -$18.52M 10-Q/A · filed 2025-08-28 | -$31.60M derived: sum of 2 quarters · filed 2025-08-28 | -$45.90M derived: sum of 3 quarters · filed 2025-08-28 | -$52.03M derived: sum of 4 quarters · filed 2025-08-28 | ||||
| 2022-12-31 | -$13.08M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | -$27.39M derived: sum of 2 quarters · filed 2025-08-28 | -$33.52M derived: sum of 3 quarters · filed 2025-08-28 | -$40.65M 10-K/A · filed 2025-08-28 | ||||
| 2022-09-30 | -$14.30M 10-Q · filed 2023-11-14 | -$20.43M derived: sum of 2 quarters · filed 2023-11-14 | -$27.57M 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$6.13M 10-Q · filed 2023-10-20 | -$13.27M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |